eISSN: 2345-5004
Editorial Board
Aims and Scope
Current Issue
All Issues
Search
Sitemap
Contact Us
Rss

Open Access

ICMJE

WAME

Renal Pathology Society

publication ethics

Journal of Herbmed Pharmacology 2017;6(4):153-159. doi:
A new and simple non-chromatographic method for isolation of drug/linker constructs: vc-MMAE evaluation

Original Article

Meghdad Abdollahpour-Alitappeh 1, Mahdi Habibi-Anbouhi 2, Saeed Balalaie 3, Farhad Golmohammadi 3, Majid Lotfinia 4, Mohsen Abolhassani 1 *

1 Hybridoma Lab, Immunology Department, Pasteur Institute of Iran, Tehran, Iran
2 National Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran
3 Peptide Chemistry Research Group, K.N. Toosi University of Technology, Tehran, Iran
4 Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran


Hybridoma Lab, Immunology Department, Pasteur Institute of Iran, Tehran, Iran
Email: AbolhassaniAbolhassani@tums.ac.ir

Abstract
Introduction: Auristatin and its derivatives (synthetic analogues of dolastatin 10, an antineoplastic natural product), are highly potent antimitotic agents which have attracted considerable attention because of their cytotoxic activity when targeting tumor cells in the form of antibody-drug conjugates (ADCs). Some sophisticated and expensive equipment such as HPLC are needed for drug/linker isolation. The aim of this study was to provide a simple aqueous work-up procedure for the isolation of such drug/linker constructs. The anti-tumor activity of the extracted drug/linker was also investigated against SKBR3 and HEK293 cancer cell lines, and cell viability was assessed.Methods: In the present study, monomethyl auristatin E (MMAE), a derivative of the cytotoxic tubulin modifier auristatin E, was covalently coupled to maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl (MC-vc-PAB), a cathepsin-B-cleavable linker, to obtain MC-vc-PAB-MMAE (vc-MMAE). Afterwards, a non-chromatographic isolation procedure was developed to isolate the drug/linker (vc-MMAE) construct. Silica gel thin-layer chromatography and electrospray ionization mass spectrometry were used to monitor the isolation procedure and to confirm the coupling of the linker to the drug, respectively. Further, the anti-tumor activity of the extracted drug/linker was investigated against SKBR3 and HEK293 cancer cell lines, and cell viability was assessed.Results: After coupling, the isolation process was confirmed as a single spot on the TLC plate. The isolation yield was calculated to be 65%. [M + H]+, [M + 2Na]+ and [M + ACN + 2H]+ species were observed in the mass spectra, showing that the coupling of MMAE to the linker is not adversely affected by the workup method. Our data revealed that the isolated vc-MMAE was highly potent against tumor cell lines, exhibiting that the workup procedure did not affect MMAE-mediated cytotoxicity.Conclusion: The isolation method described in this study can be applied for the development of a wide variety of ADCs.

Key words
Isolation, Drug/linker conjugation, Dolastatin, Antibody-drug conjugate


Comments
First name  
Last name  
Email address  
Comments  
Security code



Article
PDF


Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks

Cite by
Google Scholar


Google Scholar
Articles by Meghdad Abdollahpour-Alitappeh
Articles by Mahdi Habibi-Anbouhi
Articles by Saeed Balalaie
Articles by Farhad Golmohammadi
Articles by Majid Lotfinia
Articles by Mohsen Abolhassani
Similar articles
Related articles

PubMed
Articles by Meghdad Abdollahpour-Alitappeh
Articles by Mahdi Habibi-Anbouhi
Articles by Saeed Balalaie
Articles by Farhad Golmohammadi
Articles by Majid Lotfinia
Articles by Mohsen Abolhassani


Article Access Statistics
Viewed
PDF Downloaded
Comments

Share this article!
Creative Commons Attribution 4.0 License This work is licensed under a Creative Commons Attribution 4.0 License.
Copyright © 2015 by Journal of Herbmed Pharmacology (JHP)